Lichtstein D, Lutz R A, Xu H, Rodbard D
J Hypertens Suppl. 1986 Dec;4(5):S227-9.
Cardiac glycoside binding to rat heart and brain membrane preparations was measured by a rapid filtration technique. Data were analysed using quantitative computer analysis. The experimental results were consistent with a model in which cardiac glycoside-specific binding occurs at two independent classes of sites. The high-affinity sites in heart membranes were characterized by dissociation constants (Kd) of 40, 50, and 61 nmol/l for ouabain, digoxin and digitoxin, respectively, and the lower-affinity sites were characterized by Kd of 2.3 mumol/l, 67 nmol/l and 71 nmol/l for ouabain, digoxin and digitoxin, respectively. Comparable results were obtained using brain membranes. Potassium ions inhibit [3H]-ouabain binding in a dose-dependent manner with an IC50 of 500 mumol/l. Quantitative computer modeling indicated that potassium inhibits ouabain binding to approximately the same extent at both classed of binding sites, consistent with the hypothesis that the two classes of binding sites for cardiac glycosides might be associated with the Na+K+-ATPase.
采用快速过滤技术测定强心苷与大鼠心脏和脑膜制剂的结合。使用定量计算机分析对数据进行分析。实验结果与一个模型相符,在该模型中,强心苷特异性结合发生在两类独立的位点。心脏膜中的高亲和力位点,哇巴因、地高辛和洋地黄毒苷的解离常数(Kd)分别为40、50和61 nmol/L,而低亲和力位点,哇巴因、地高辛和洋地黄毒苷的Kd分别为2.3 μmol/L、67 nmol/L和71 nmol/L。使用脑膜也获得了类似的结果。钾离子以剂量依赖的方式抑制[3H] - 哇巴因结合,IC50为500 μmol/L。定量计算机建模表明,钾在两类结合位点上对哇巴因结合的抑制程度大致相同,这与强心苷的两类结合位点可能与Na + K + -ATP酶相关的假设一致。